Effect of normal saline on cisplatin pharmacokinetics and antitumor activity in mice bearing P388 leukemia

R. A. Fulco, M. Vannozzi, P. Collecchi, F. Merlo, B. Parodi, D. Civalleri, M. Esposito

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The effect of normal saline (NS) on the antitumor activity, toxicity and pharmacokinetic of cisplatin (DDP) was investigated in BDF1 mice bearing P388 leukemia. Tumorbearing mice received 8 or 16 mg/Kg of DDP dissolved in NS or distilled water (DW) intraperitoneally. Control animals were treated with DW or NS alone. The administration of 8 mg/Kg of DDP+NS produced a significantly better survival (P <0.05) compared to that observed in mice receiving DDP+DW. The proportion of long-term survivors was 3.5 times higher in the DDP+NS group (39%) compared to the DDP+DW group (11%). The administration of 16 mg/kg DDP+DW was highly toxic, resulting in early deaths (MST = 5 days) and no long-term survivors. NS protected from DDP toxicity without further improving the survival achieved following the injection of 8 mg/kg DDP+NS. Investigation of platinum pharmacokinetics showed that NS significantly decreases both plasma and tissue concentrations of total platinum, mainly through a decrease in the amount of platinum bound to high molecular weight plasma proteins. HPLC studies indicated that mice receiving 8 mg/kg DDP+NS or DDP+DW fail to show clear differences both in the total ultrafilterable platinum and unchanged DDP in plasma ultrafiltrate. Conversely, mice treated with DDP+NS had higher concentrations of platinum-species in plasma ultrafiltrate than mice receiving DDP+DW. These latter results, together with the observation that NS decreases the amount of platinum bound to plasma proteins, suggest that the effect of NS does not solely depend in vivo on the ability of the chloride ion concentration to stabilize the DDP molecule and suppress the formation of DDP metabolites, but also on its ability to prevent DDP toxicity by reducing the protein binding of DDP aquated products.

Original languageEnglish
Pages (from-to)1603-1610
Number of pages8
JournalAnticancer Research
Volume10
Issue number6
Publication statusPublished - 1990

Fingerprint

Leukemia P388
Cisplatin
Platinum
Pharmacokinetics
Water
Survivors
Blood Proteins
Survival
Poisons
Protein Binding
Chlorides
Molecular Weight
High Pressure Liquid Chromatography
Ions
Injections

Keywords

  • antitumor activity
  • cisplatin
  • distilled water
  • normal saline
  • pharmacokinetics
  • toxicity

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Fulco, R. A., Vannozzi, M., Collecchi, P., Merlo, F., Parodi, B., Civalleri, D., & Esposito, M. (1990). Effect of normal saline on cisplatin pharmacokinetics and antitumor activity in mice bearing P388 leukemia. Anticancer Research, 10(6), 1603-1610.

Effect of normal saline on cisplatin pharmacokinetics and antitumor activity in mice bearing P388 leukemia. / Fulco, R. A.; Vannozzi, M.; Collecchi, P.; Merlo, F.; Parodi, B.; Civalleri, D.; Esposito, M.

In: Anticancer Research, Vol. 10, No. 6, 1990, p. 1603-1610.

Research output: Contribution to journalArticle

Fulco, RA, Vannozzi, M, Collecchi, P, Merlo, F, Parodi, B, Civalleri, D & Esposito, M 1990, 'Effect of normal saline on cisplatin pharmacokinetics and antitumor activity in mice bearing P388 leukemia', Anticancer Research, vol. 10, no. 6, pp. 1603-1610.
Fulco RA, Vannozzi M, Collecchi P, Merlo F, Parodi B, Civalleri D et al. Effect of normal saline on cisplatin pharmacokinetics and antitumor activity in mice bearing P388 leukemia. Anticancer Research. 1990;10(6):1603-1610.
Fulco, R. A. ; Vannozzi, M. ; Collecchi, P. ; Merlo, F. ; Parodi, B. ; Civalleri, D. ; Esposito, M. / Effect of normal saline on cisplatin pharmacokinetics and antitumor activity in mice bearing P388 leukemia. In: Anticancer Research. 1990 ; Vol. 10, No. 6. pp. 1603-1610.
@article{d2e07f3a014746bebdade1f79dd998ba,
title = "Effect of normal saline on cisplatin pharmacokinetics and antitumor activity in mice bearing P388 leukemia",
abstract = "The effect of normal saline (NS) on the antitumor activity, toxicity and pharmacokinetic of cisplatin (DDP) was investigated in BDF1 mice bearing P388 leukemia. Tumorbearing mice received 8 or 16 mg/Kg of DDP dissolved in NS or distilled water (DW) intraperitoneally. Control animals were treated with DW or NS alone. The administration of 8 mg/Kg of DDP+NS produced a significantly better survival (P <0.05) compared to that observed in mice receiving DDP+DW. The proportion of long-term survivors was 3.5 times higher in the DDP+NS group (39{\%}) compared to the DDP+DW group (11{\%}). The administration of 16 mg/kg DDP+DW was highly toxic, resulting in early deaths (MST = 5 days) and no long-term survivors. NS protected from DDP toxicity without further improving the survival achieved following the injection of 8 mg/kg DDP+NS. Investigation of platinum pharmacokinetics showed that NS significantly decreases both plasma and tissue concentrations of total platinum, mainly through a decrease in the amount of platinum bound to high molecular weight plasma proteins. HPLC studies indicated that mice receiving 8 mg/kg DDP+NS or DDP+DW fail to show clear differences both in the total ultrafilterable platinum and unchanged DDP in plasma ultrafiltrate. Conversely, mice treated with DDP+NS had higher concentrations of platinum-species in plasma ultrafiltrate than mice receiving DDP+DW. These latter results, together with the observation that NS decreases the amount of platinum bound to plasma proteins, suggest that the effect of NS does not solely depend in vivo on the ability of the chloride ion concentration to stabilize the DDP molecule and suppress the formation of DDP metabolites, but also on its ability to prevent DDP toxicity by reducing the protein binding of DDP aquated products.",
keywords = "antitumor activity, cisplatin, distilled water, normal saline, pharmacokinetics, toxicity",
author = "Fulco, {R. A.} and M. Vannozzi and P. Collecchi and F. Merlo and B. Parodi and D. Civalleri and M. Esposito",
year = "1990",
language = "English",
volume = "10",
pages = "1603--1610",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "6",

}

TY - JOUR

T1 - Effect of normal saline on cisplatin pharmacokinetics and antitumor activity in mice bearing P388 leukemia

AU - Fulco, R. A.

AU - Vannozzi, M.

AU - Collecchi, P.

AU - Merlo, F.

AU - Parodi, B.

AU - Civalleri, D.

AU - Esposito, M.

PY - 1990

Y1 - 1990

N2 - The effect of normal saline (NS) on the antitumor activity, toxicity and pharmacokinetic of cisplatin (DDP) was investigated in BDF1 mice bearing P388 leukemia. Tumorbearing mice received 8 or 16 mg/Kg of DDP dissolved in NS or distilled water (DW) intraperitoneally. Control animals were treated with DW or NS alone. The administration of 8 mg/Kg of DDP+NS produced a significantly better survival (P <0.05) compared to that observed in mice receiving DDP+DW. The proportion of long-term survivors was 3.5 times higher in the DDP+NS group (39%) compared to the DDP+DW group (11%). The administration of 16 mg/kg DDP+DW was highly toxic, resulting in early deaths (MST = 5 days) and no long-term survivors. NS protected from DDP toxicity without further improving the survival achieved following the injection of 8 mg/kg DDP+NS. Investigation of platinum pharmacokinetics showed that NS significantly decreases both plasma and tissue concentrations of total platinum, mainly through a decrease in the amount of platinum bound to high molecular weight plasma proteins. HPLC studies indicated that mice receiving 8 mg/kg DDP+NS or DDP+DW fail to show clear differences both in the total ultrafilterable platinum and unchanged DDP in plasma ultrafiltrate. Conversely, mice treated with DDP+NS had higher concentrations of platinum-species in plasma ultrafiltrate than mice receiving DDP+DW. These latter results, together with the observation that NS decreases the amount of platinum bound to plasma proteins, suggest that the effect of NS does not solely depend in vivo on the ability of the chloride ion concentration to stabilize the DDP molecule and suppress the formation of DDP metabolites, but also on its ability to prevent DDP toxicity by reducing the protein binding of DDP aquated products.

AB - The effect of normal saline (NS) on the antitumor activity, toxicity and pharmacokinetic of cisplatin (DDP) was investigated in BDF1 mice bearing P388 leukemia. Tumorbearing mice received 8 or 16 mg/Kg of DDP dissolved in NS or distilled water (DW) intraperitoneally. Control animals were treated with DW or NS alone. The administration of 8 mg/Kg of DDP+NS produced a significantly better survival (P <0.05) compared to that observed in mice receiving DDP+DW. The proportion of long-term survivors was 3.5 times higher in the DDP+NS group (39%) compared to the DDP+DW group (11%). The administration of 16 mg/kg DDP+DW was highly toxic, resulting in early deaths (MST = 5 days) and no long-term survivors. NS protected from DDP toxicity without further improving the survival achieved following the injection of 8 mg/kg DDP+NS. Investigation of platinum pharmacokinetics showed that NS significantly decreases both plasma and tissue concentrations of total platinum, mainly through a decrease in the amount of platinum bound to high molecular weight plasma proteins. HPLC studies indicated that mice receiving 8 mg/kg DDP+NS or DDP+DW fail to show clear differences both in the total ultrafilterable platinum and unchanged DDP in plasma ultrafiltrate. Conversely, mice treated with DDP+NS had higher concentrations of platinum-species in plasma ultrafiltrate than mice receiving DDP+DW. These latter results, together with the observation that NS decreases the amount of platinum bound to plasma proteins, suggest that the effect of NS does not solely depend in vivo on the ability of the chloride ion concentration to stabilize the DDP molecule and suppress the formation of DDP metabolites, but also on its ability to prevent DDP toxicity by reducing the protein binding of DDP aquated products.

KW - antitumor activity

KW - cisplatin

KW - distilled water

KW - normal saline

KW - pharmacokinetics

KW - toxicity

UR - http://www.scopus.com/inward/record.url?scp=0025636340&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025636340&partnerID=8YFLogxK

M3 - Article

VL - 10

SP - 1603

EP - 1610

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 6

ER -